Plain-English translation of NCT05864794 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a special brain imaging scan called MRI can help doctors find cancer that may have spread to the brain in patients with newly diagnosed advanced non-small cell lung cancer. Right now, doctors don't routinely screen for brain disease in these patients unless they have symptoms. The study wants to see if finding this disease early—before symptoms appear—might help improve outcomes.
Advanced lung cancer often spreads to the brain, sometimes without causing noticeable symptoms. By the time brain disease is detected through symptoms alone, it may be too late to treat effectively. This study is exploring whether screening everyone with advanced lung cancer early could catch this spread sooner and potentially improve results.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will have one brain MRI scan with contrast dye to look for any signs of cancer spread. The scan itself takes about 30–45 minutes. You will receive the results and your doctor will discuss any findings with you and explain next steps for your cancer care.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
Netherlands